Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]
Solana-Altabella A +26 more
europepmc +1 more source
Blastic plasmacytoid dendritic cell neoplasm secondary to acute myeloid leukemia with shared mutations in TET2 and DNMT3A: a case report and literature review. [PDF]
Sun Y +5 more
europepmc +1 more source
Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasm. [PDF]
Wang M +15 more
europepmc +1 more source
Clinico-hematopathologic and Genetic Characteristics of Korean Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Single-Center Cohort Study. [PDF]
Kim J +16 more
europepmc +1 more source
Real-world management of blastic plasmacytoid dendritic cell neoplasm at an academic center with a broad regional referral base. [PDF]
Krah NM +6 more
europepmc +1 more source
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]
Khalife-Hachem S +15 more
europepmc +1 more source
Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology. [PDF]
Anzelc M +3 more
europepmc +1 more source
Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]
Hassan SL, Chatha DE.
europepmc +1 more source
A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm on the Chest. [PDF]
Tokioka R, Saito-Sasaki N, Sawada Y.
europepmc +1 more source
Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]
Lee BJ.
europepmc +1 more source

